We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$956M
AUM Growth
-$88.9M
Cap. Flow
-$124M
Cap. Flow %
-13%
Top 10 Hldgs %
51.28%
Holding
904
New
257
Increased
162
Reduced
180
Closed
232

Sector Composition

Rank Sector Weight
1 Healthcare 36.98%
2 Financials 14.53%
3 Materials 10.99%
4 Energy 8.52%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMCAW
451
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
$6.05K ﹤0.01%
110,008
+10,008
+10% +$525
MOBVW
452
DELISTED
Mobiv Acquisition Corp Warrant
MOBVW
$6K ﹤0.01%
+100,000
New +$7.52K
PIAI.WS
453
DELISTED
Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PIAI.WS
$5.98K ﹤0.01%
300,399
+439
+0.1% +$10
NRACW
454
DELISTED
Northern Revival Acquisition Corporation Warrant
NRACW
$5.97K ﹤0.01%
119,185
+69,185
+138% +$1.89K
SHPWW
455
DELISTED
Shapeways Holdings, Inc. Warrants
SHPWW
$5.97K ﹤0.01%
353,221
+949
+0.3% +$27
ZINGW
456
DELISTED
FTAC Zeus Acquisition Corp. Warrant
ZINGW
$5.92K ﹤0.01%
296,147
+124,830
+73% +$5.55K
PGYWW
457
Pagaya Technologies Ltd Warrants
PGYWW
$1.31M
$5.83K ﹤0.01%
+61,460
New +$8.04K
ADP icon
458
PUT
Automatic Data Processing
ADP
$108B
$5.66K ﹤0.01%
+37,700
New +$9.26M
GSQB.WS
459
DELISTED
G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
GSQB.WS
$5.59K ﹤0.01%
139,424
+37,724
+37% +$2.48K
NVSAW
460
DELISTED
New Vista Acquisition Corp. Warrant
NVSAW
$5.56K ﹤0.01%
96,438
-11,895
-11% -$839
BMRN icon
461
CALL
BioMarin Pharmaceuticals
BMRN
$13.5B
$5.5K ﹤0.01%
+10,000
New +$939K
RKLY.WS
462
DELISTED
Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an exercise price of $11.50
RKLY.WS
$5.49K ﹤0.01%
109,781
-4,144
-4% -$223
VBOCW
463
DELISTED
Viscogliosi Brothers Acquisition Corp Warrant
VBOCW
$5.43K ﹤0.01%
100,000
CLDI.WS
464
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$5.39K ﹤0.01%
107,900
-50,200
-32% -$1.88K
ACACW
465
DELISTED
Acri Capital Acquisition Corp Warrant
ACACW
$5.36K ﹤0.01%
153,250
+59,500
+63% +$2.52K
OPTXW icon
466
Syntec Optics Holdings Warrant
OPTXW
$22.9M
$5.34K ﹤0.01%
164,375
+20,356
+14% +$702
IPVIW
467
DELISTED
InterPrivate IV InfraTech Partners Inc. Warrant
IPVIW
$5.31K ﹤0.01%
132,552
+115,176
+663% +$5.85K
LDHAW
468
DELISTED
LDH Growth Corp I Warrant
LDHAW
$5.27K ﹤0.01%
239,667
+141,423
+144% +$5.93K
BIIB icon
469
PUT
Biogen
BIIB
$30.1B
$5.25K ﹤0.01%
+4,300
New +$1.21M
IGACW
470
DELISTED
IG Acquisition Corp. Warrant
IGACW
$5.23K ﹤0.01%
200,171
-82,919
-29% -$8.23K
TBCPW
471
DELISTED
Thunder Bridge Capital Partners III Inc. Warrant
TBCPW
$5.21K ﹤0.01%
+68,000
New +$4.2K
EMCGW
472
DELISTED
Embrace Change Acquisition Corp Warrants
EMCGW
$5.16K ﹤0.01%
+158,900
New +$6.04K
SPKBW
473
DELISTED
Silver Spike Acquisition Corp II Warrant
SPKBW
$5.06K ﹤0.01%
168,758
+716
+0.4% +$24
SLVRW
474
DELISTED
SilverSPAC Inc. Warrant
SLVRW
$5.06K ﹤0.01%
29,900
-100
-0.3% -$18
LBBBW
475
DELISTED
Lakeshore Acquisition II Corp. Warrants
LBBBW
$5.05K ﹤0.01%
101,012
-45,491
-31% -$3.63K

Similar funds

Cowen and Company's Q4 2022 Portfolio in Review

As of Q4 2022, Cowen and Company held 904 positions worth $956M, down 8.5% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cowen and Company withdrew a net $124M in Q4 2022, closing 232 positions and reducing 180 holdings. Its most notable exit was ARK Innovation ETF, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Financials and Materials.

Against the trend, Cowen and Company opened a new position in DCP Midstream, LP worth $58.8M.

  • Cowen and Company's largest Q4 2022 buy was DCP Midstream, LP: 1,516,562 shares worth $58.8M.
  • Cowen and Company added most to Adicet Bio in Q4 2022, an estimated $10.9M increase.
  • Cowen and Company's biggest Q4 2022 reduction was Immunocore, cutting an estimated $34.1M.
  • Cowen and Company fully exited ARK Innovation ETF in Q4 2022, selling an estimated $131M.
  • Cowen and Company's ten largest holdings make up 51% of its $956M portfolio in Q4 2022.
  • Cowen and Company opened 257 new positions and closed 232 in Q4 2022.
  • Cowen and Company's portfolio value fell 8.5% quarter-over-quarter to $956M.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.